• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Expression of capsular polysaccharide during experimental focal infection with Staphylococcus aureus.

作者信息

Arbeit R D, Dunn R M

机构信息

Infectious Diseases Section, Veterans Administration Medical Center, Boston, Massachusetts 02130.

出版信息

J Infect Dis. 1987 Dec;156(6):947-52. doi: 10.1093/infdis/156.6.947.

DOI:10.1093/infdis/156.6.947
PMID:3680994
Abstract

In vivo expression of the type 8 capsular polysaccharide (CP) of Staphylococcus aureus was studied by using the Becker strain, the prototype type 8 strain, in a guinea pig model of persistent subcutaneous infection. At 24 hr after infection, supernatants of aspirates from the site of infection contained low levels of CP (median, 0.53 ng/ml; range, less than 0.16-6.30 ng/ml). CP levels increased at day 3 to a geometric mean level of 47 ng/ml, at day 6 to 389 ng/ml, at day 8 to 537 ng/ml, and thereafter persisted in that range. On days 1, 3, and 6, CP was not detectable (less than 0.16 ng/ml) in the serum, but on days 8, 10, or 13, CP was present in 15 (58%) of 26 animals; the median peak level of serum CP among these animals was 2.00 ng/ml (range, 0.31-5.90 ng/ml). These studies document that the type 8 CP of S. aureus is produced and released during a focal, suppurative infection and can be detected in the serum of infected animals.

摘要

相似文献

1
Expression of capsular polysaccharide during experimental focal infection with Staphylococcus aureus.
J Infect Dis. 1987 Dec;156(6):947-52. doi: 10.1093/infdis/156.6.947.
2
Capsular polysaccharide antigenemia in rats with experimental endocarditis due to Staphylococcus aureus.
J Infect Dis. 1987 Feb;155(2):242-6. doi: 10.1093/infdis/155.2.242.
3
Evaluation of serotypes 5 and 8 capsular polysaccharides in protection against Staphylococcus aureus in murine models of infection.在小鼠感染模型中评估5型和8型荚膜多糖对金黄色葡萄球菌的保护作用。
Hum Vaccin Immunother. 2017 Jul 3;13(7):1609-1614. doi: 10.1080/21645515.2017.1304334. Epub 2017 Apr 19.
4
Detection of capsular polysaccharide in milk of cows with natural intramammary infection caused by Staphylococcus aureus.检测由金黄色葡萄球菌引起的自然乳房内感染奶牛乳汁中的荚膜多糖。
Am J Vet Res. 1990 Nov;51(11):1857-9.
5
Respiratory activity is essential for post-exponential-phase production of type 5 capsular polysaccharide by Staphylococcus aureus.呼吸活动对于金黄色葡萄球菌在指数生长期后产生5型荚膜多糖至关重要。
Infect Immun. 1996 Jul;64(7):2408-14. doi: 10.1128/iai.64.7.2408-2414.1996.
6
Production of type 5 capsular polysaccharide by Staphylococcus aureus grown in a semi-synthetic medium.在半合成培养基中生长的金黄色葡萄球菌产生5型荚膜多糖。
J Gen Microbiol. 1991 May;137(5):1155-62. doi: 10.1099/00221287-137-5-1155.
7
Purified capsular polysaccharide-induced immunity to Staphylococcus aureus infection.纯化荚膜多糖诱导对金黄色葡萄球菌感染的免疫力。
J Infect Dis. 1988 Apr;157(4):723-30. doi: 10.1093/infdis/157.4.723.
8
Role of bacterial exopolymers and host factors on adherence and phagocytosis of Staphylococcus aureus in foreign body infection.细菌胞外聚合物和宿主因素在异物感染中对金黄色葡萄球菌黏附和吞噬作用的作用
J Infect Dis. 1987 Mar;155(3):524-31. doi: 10.1093/infdis/155.3.524.
9
Involvement of the accessory gene regulator (agr) in expression of type 5 capsular polysaccharide by Staphylococcus aureus.附属基因调节因子(agr)在金黄色葡萄球菌5型荚膜多糖表达中的作用。
J Gen Microbiol. 1993 Jun;139 Pt 6:1301-6. doi: 10.1099/00221287-139-6-1301.
10
Staphylococcus aureus growth and type 5 capsular polysaccharide production in synthetic media.金黄色葡萄球菌在合成培养基中的生长及5型荚膜多糖的产生
Appl Environ Microbiol. 1991 Feb;57(2):618-21. doi: 10.1128/aem.57.2.618-621.1991.

引用本文的文献

1
Prophylactic use of incisional negative pressure wound therapy for groin incisions in vascular surgery: randomized clinical trial.血管外科腹股沟切口预防性使用切口负压伤口治疗:随机临床试验
BJS Open. 2025 May 7;9(3). doi: 10.1093/bjsopen/zraf059.
2
Antibodies to Staphylococcus aureus capsular polysaccharides 5 and 8 perform similarly in vitro but are functionally distinct in vivo.抗金黄色葡萄球菌荚膜多糖 5 型和 8 型抗体在体外具有相似的性能,但在体内具有不同的功能。
Virulence. 2017 Aug 18;8(6):859-874. doi: 10.1080/21505594.2016.1270494. Epub 2016 Dec 9.
3
Suppression of surgeons' bacterial hand flora during surgical procedures with a new antimicrobial surgical glove.
使用新型抗菌手术手套在手术过程中抑制外科医生手部细菌菌群
Surg Infect (Larchmt). 2014 Feb;15(1):43-9. doi: 10.1089/sur.2012.230. Epub 2013 Oct 12.
4
An experimental study exploring the relationship between the size of bacterial inoculum and bacterial adherence to prosthetic mesh.一种探索细菌接种物大小与细菌对人工网片黏附之间关系的实验研究。
Surg Endosc. 2013 Mar;27(3):978-85. doi: 10.1007/s00464-012-2545-4. Epub 2012 Oct 6.
5
Bacterial colonization of bone allografts: establishment and effects of antibiotics.同种异体骨移植物的细菌定植:抗生素的建立和作用。
Clin Orthop Relat Res. 2010 Aug;468(8):2113-21. doi: 10.1007/s11999-010-1322-8.
6
Staphylococcus aureus capsular polysaccharides.金黄色葡萄球菌荚膜多糖
Clin Microbiol Rev. 2004 Jan;17(1):218-34. doi: 10.1128/CMR.17.1.218-234.2004.
7
Heterogeneity of cell-associated CP5 expression on Staphylococcus aureus strains demonstrated by flow cytometry.通过流式细胞术证明金黄色葡萄球菌菌株上细胞相关CP5表达的异质性。
Clin Diagn Lab Immunol. 1997 May;4(3):275-8. doi: 10.1128/cdli.4.3.275-278.1997.
8
A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge.一种金黄色葡萄球菌荚膜多糖(CP)疫苗和CP特异性抗体可保护小鼠免受细菌攻击。
Infect Immun. 1996 May;64(5):1659-65. doi: 10.1128/iai.64.5.1659-1665.1996.
9
Effects of in vitro and in vivo growth conditions on expression of type 8 capsular polysaccharide by Staphylococcus aureus.体外和体内生长条件对金黄色葡萄球菌8型荚膜多糖表达的影响。
Infect Immun. 1993 May;61(5):1853-8. doi: 10.1128/iai.61.5.1853-1858.1993.
10
Effects of culture conditions on production of type 5 capsular polysaccharide by human and bovine Staphylococcus aureus strains.培养条件对人源和牛源金黄色葡萄球菌菌株5型荚膜多糖产生的影响。
Clin Diagn Lab Immunol. 1995 Mar;2(2):166-71. doi: 10.1128/cdli.2.2.166-171.1995.